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INTRODUCTION, SUMMARY, AND PERSPECTIVES 
The b-type cytochromes are a class of electron-transfer proteins, which, by 
definition, contain a noncovalently bound heme (protoporphyrin IX) as 
IThe following abbreviations are used: Q, ubiquinone; QH2' reduced ubiquinone; QH·, 
Ubiquinone radical; DQ, duroquinone; MQ, menaquinone. 
2Some of the studies reported were supported by a grant of the Deutsche Forschungsgemein-
schaft to Gebhard von Jagow. 
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prosthetic group (1, 2). These cytochromes exhibit a high structural diver-
sity, and they function in a variety ofredox reactions and electron transfer 
chains in aerobic, anaerobic (3, 4), and photosynthetic (5) bacteria, as well 
as in eukaryotic animal and plant cells (5). In some of these systems, the 
oxidation energy is conserved for the synthesis of ATP. 
This review concentrates on three examples of membrane-bound b cyto-
chromes: (a) cytochrome b5 of liver microsomes, (b) the b cytochromes 
involved in the reduction of nitrate and fumarate in the cytoplasmic mem-
brane of anaerobic bacteria, and (c) the b cytochromes of the respiratory 
chain of the mitochondrial inner membrane. These cytochromes vary in 
structural complexity from the molecularly dispersed microsomal cyto-
chrome b 5, to the b cytochromes that are subunits of likewise simple 
complexes of two to four different subunits, and finally to the dimeric 
cytochrome b of the highly complicated mitochondrial unbiquinol: cyto-
chrome c reductase which contains at least eight additional subunit poly-
peptides. 
In recent years considerable progress has been achieved in the isolation, 
structural and functional analysis, and even the reconstitution of these 
intrinsic membrane proteins. Former soluble preparations of some of these 
b-cytochromes have originated from the action of proteases, and the com-
plete proteins could only be solubilized and purified in the presence of mild 
detergents. Multisubunit complexes containing b cytochromes as QH2 : 
nitrate reductase, MQH2 : fumarate reductase, succinate: Q reductase, and 
QH2: cytochrome c reductase could be isolated in a functional state. Con-
trolled dissociation of such complexes lead to the isolation of partial com-
plexes devoid of certain subunits and functional properties. The most 
intricate cytochrome b, that of the mitochondrial QH2 : cytochrome c re-
ductase, could be obtained as a dimer that retained at least some of its 
functional properties. 
Amino acid sequence analysis of hydrophobic polypeptides is still prob-
lematic. The primary structure of the membrane-integrated segment of 
microsomal cytochrome b5 has now been elucidated for several species. 
Partial sequences of the extremely hydrophobic mitochondrial cytochrome 
b have been determined, and the further sequence analysis of this 30,000-
dalton polypeptide probably will profit from studies of the nucleotide se-
quence of the structural gene. In general, the few available complete 
primary structures indicate that evolutionarily unrelated b-cytochromes 
exist. Three-dimensional structures show different types of cytochrome fold 
as well as histidine-histidine and histidine-methionine as heme-liganding 
residues. 
An essential question concerns the topology (6) of the membrane-bound 
b-cytochromes. The heme-carrying segment of cytochrome b5 appears to 
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be in contact with the water-phase of the cytoplasm, while the hydrophobic 
segment only anchors the protein in the membrane. The multisubunit com-
plexes, however, span the membrane assymetrically with different polypep-
tides being accessible from the two faces of the membrane. The bacterial 
cytochrome b of the QH2: nitrate reductase is found solely at the periplas-
mic side of the membrane, while the mitochondrial cytochrome b itself 
possibly traverSes the membrane as a dimer. 
The identification of the immediate physiological electron donors and 
acceptors still poses a major problem. The situation appears to be clear with 
microsomal cytochrome bs in so far as the constituents of a stearyl-CoA 
desaturase system have been isolated and reconstituted. The system re-
quires, besides cytochrome bs, a NADH-linked cytochrome bs reductase 
and the desaturase. Both the reductase and the desaturase are probably 
amphipathic proteins, which difuse freely in the membrane like the cyto-
chrome. The redox centres of the three proteins are all oriented toward the 
same side of the membrane, and the redox reactions occur after diffusion-
controlled collision of the proteins. In situ, cytochrome b s may have addi-
tional redox partners that are not yet unequivocally identified. Further-
more, in the case of the cytochrome b s of the erythrocyte methemoglobin 
reductase system it was postulated that an alteration of structure and bio-
logical function of the cytochrome occurs during maturation of the red 
blood cell. In the case of the b cytochromes of the multisubunit complexes, 
the pathway of the electron is more difficult to elucidate. In all these systems 
a quinone appears to be one of the redox partners (7). The Escherichia coli 
QH2: nitrate reductase constitutes a transmembrane electron pathway. Its 
cytochrome b reacts with ubiquinol at the periplasmic surface. The nitrate 
reducase moiety contains a further two redox centres whose sequence is still 
unknown. The electron flow from formate to fumarate in Vibrio succino-
genes is also organized transmembranously. Two distinct b cytochromes 
are involved, most likely as reductase and oxidase of menaquinone. The 
topology of these b cytochromes, however, is unknown. Two different 
additional redox centres detected in isolated partial complexes are possibly 
the other protein redox partners of the cytochrome. An especially sophis-
ticated electron-transfer protein is represented by the dimeric b cytochrome 
of the mitochondrial QH2 : cytochrome c reductase. The isolated cyto-
chrome shows, as the protein in situ, two different half-reduction potentials, 
even though both subunits are very similar or even identical. It is unclear 
whether both b cytochromes are arranged in parallel, in series, or otherwise. 
The flow of the electron is highly controversial. We depict two alternatives 
schematically: (a) the Q cycle involving bound QH radicals and (b) a more 
classical sequence involving QH2 as reductant and an iron-sulfur protein 
as oxidant of the b cytochromes. 
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Some of the cytochrome b-containing electron-transfer chains conserve 
the free energy of oxidation as a transmembranous proton potential that can 
be used for the synthesis of ATP (8). At the present state of knowledge it 
appears likely that a proton gradient can be produced by different mecha-
nisms. 1. The E. coli QH2 : nitrate reductase system which transfers elec-
trons across the membrane from a proton-producing half-reaction (QH2 
oxidation) at the periplasmic face to a proton-consuming half-reaction (ni-
trate reduction) at the cytoplasmic face. A corresponding mechanism ap-
pears to function in the vectorial formate: fumarate reductase system of V. 
succinogenes. 2. In the case of the mitochondrial QH2 : cytochrome c reduc-
tase (site 11 of oxidative phosphorylation) the proton movements associated 
with the overall redox reactions cannot account for the proton/e ratios that 
have been observed in situ. An attractive hypothesis postulates that a pro-
tein constituent of the complex exhibits true proton-pumping abilities. The 
cytochrome b dimer appears to be a likely candidate for such a proton 
pump since its redox centres show a pH dependence. An alternative and at 
this time already classical hypothesis postulates a "Q" cycle. Here the 
protons are translocated by the quinone, which is reduced and oxidized at 
multiple sites of the complex located at different faces of the membrane. 
A section on the biogenesis and genetics of mitochondrial cytochrome 
b is included below. Cytochrome b of the QH2: cytochrome c reducatase 
has been shown to be a mitochondrial gene and translation product. A 
library of mutants with defective or modified cytochrome b is now available 
which should be extremely useful for a further elucidation of the structural 
and functional properties of this intricate b-type cytochrome. 
CYTOCHROME bs 
Microsomal cytochrome b 5 is a membrane-bound protein functioning as a 
component of the NADH-dependent a9 stearyl CoA desaturase system (9, 
10). It has also been implicated in NADPH-linked microsomal hydroxyla-
tion reactions (11, 12). Additionally, in the supernatant fraction of ery-
throcytes a soluble cytochrome b 5 is present which participates in the 
reduction of methemoglobin by transferring electrons from erythrocyte 
cytochrome b 5 reductase to methemoglobin (13, 14). 
The microsomal cytochrome b5 in its native state is an amphipathic 
protein with an Mr of 16,000 (15). It contains two domains: a hydrophilic, 
catalytic segment consisting of about 80 amino acid residues, and a hydro-
phobic segment that is required for binding the cytochrome to the microso-
mal membrane (15, 16). Controlled proteolytic digestion of the native 
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protein yields a water-soluble cytochrome b 5 with a molecular weight of 
about 11,000. The amino acid sequence of the soluble cytochrome b5 has 
been reported for several species (17, 18). From crystals of the bovine 
protein a three-dimensional structure was obtained at 2 A resolution (19). 
The structural and functional properties of the soluble cytochrome b5 have 
been extensively reviewed (2). In the following, recent information on the 
native cytochrome b5 (structure, functional properties, reconstitution, and 
biosynthesis) is presented. 
The isolation of complete cytochrome b 5 from liver endoplasmatic reticu-
lum requires solubilization and fractionation in the presence of detergents 
(15, 17, 20). In a recently improved purification procedure 2% Triton 
X-lOO was applied (21). The final protein, exhibiting a ratio of OD2801 
OD413 lower than 0.36, is soluble in the absence of detergent. Aggregates 
of cytochrome b 5, apparently octamers, form at neutral or slightly alkaline 
pH values and 0.02-0.4 ionic strength (21). 
Amino acid sequences of the hydrophobic segment of cytochrome b5 
from porcine (22), equine (23), bovine (24), and rabbit (25) have been 
published recently. This nonpolar peptide is present at the COOH-terminus 
of the complete cytochrome b 5, which (in equine) now consists of a total 
of 133 residues (see Figure 1). The four established sequences from porcine, 
horse, bovine, and rabbit show extensive homology. The sequence of resi-
dues 104-126 contains only hydrophobic or uncharged hydrophilic side 
chains. The basic and acidic amino acid residues occur at the COOH-
terminus and in the peptide linking the membranous segment to the globu-
lar heme-carrying segment. Such residues may be expected to be present 
90 lOO 110 
Porcine 
-lIe-Ala-Lys- Pro-Ser-Glu-Thr-Leu -lie - Thr-Thr-Val- Glu - Ser-Asn-Ser-Ser-Trp-Trp-Thr -Asn-Trp 
Equine - Ser-Lys -lie - Ala -Lys -Pro-Val-Glu - Thr -Leu-lIe - Thr - Thr-Val- Asp-Ser- Asn-Ser-Ser-Trp-Trp-Thr-Asn-Trp 
Bovine -lie - Thr-Lys-Pro-Ser-Glu-Ser -lIe-lIp-Thr - Thr -lie - Asp-Ser-Asn-Pro-5er-Trp-Trp- Thr-Asn-Trp 
Rabbit -Mpt-Gln-Thr-Leu -lle-Thr-Thr - Val- Asp-Ser -Asn-Ser-Spr-Trp-Trp- Thr -Asn -Trp 
120 130 
Porcine Val-Ile - Pro-Ala-Ile-Spr -Ala -Leu-Val-Val-Spr-Leu-Mpl-Tyr-His-Phe-Tyr-Thr-Ser -Glu-Asn 
Equine 
Bovine 
~abbit 
Val-lIe -Pro-Ala -Ill' - Ser -Ala-Val-VaI-Val-Ala-Leu -Met-Tyr-Arg-lIp-Tyr-Thr-Ala-Glu-Asp 
Lpu-Ilp-Pro-Ala -Ill' - Ser -Ala-Leu-Phe-Val-Ala-Lpu-lIe- Tyr- His-Lpu-Tyr-Thr-Ser-Glu-Asn 
Val-lIe -Pro-Ala -lie - Spr - Ala- Lpu -lle-Val-Ala- Leu-Met -Tyr-Arg-Leu-Tyr - Met-Ala -Asp-Asp 
Figure 1 Amino acid sequences of the hydrophobic segment of apocytochrome b s from the 
liver of porcine (22), equine (23), bovine (24), and rabbit (25). For the sequence of the 
heme-carrying segment see (2, 17, 18). 
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outside the hydrophobic milieu of the lipid membrane, thereby suggesting 
that the hydrophobic segment either penetrates the membrane or folds back 
on itself so that the COOH-terminus is near the cytoplasmic surface of the 
membrane. The results of a predictive analysis for conformational features 
(22, 24) according to the rules of Chou & Fasman (26, 27), are similar for 
the amino acid sequence of the membranous segment from horse, equine, 
and bovine. The sequence 103-112, which contains a cluster of three trypto-
phanyl residues, seems to consist of 3-4 overlapping ,8-turn structures. The 
prediction must be viewed with caution, however, since the conformational 
parameters employed were derived from studies on globular hydrophilic 
proteins and may not be necessarily extendable to membranous peptides. 
From the structure of complete cytochrome b5, it is clear that the soluble 
cytochrome b5 originated by tryptic cleavage at peptide bond 90--91 or 
88-89. In addition, a short peptide (1-6 in porcine) is removed from the 
NHrterminus. Cathepsin-produced soluble cytochrome b 5 shows serine 97 
as COOH-terminus (28). 
The complete cytochrome b 5, including the membranous segment, is 
necessary for functional reconstitution of the stearyl-CoA desaturase sys-
tem, although the soluble cytochrome b 5 accepts electrons from cyto-
chrome b5 reductase (12, 29). The spectral properties of complete 
cytochrome b5 are essentially the same as those of the soluble form (heme 
peptide segment) (21). 
The natural electron donor for cytochrome b 5 is the NADH-cytochrome 
b5 reductase (30), a flavoprotein of molecular weight 33,000 (31) which is 
tightly associated with microsomal membranes. It is interesting that the 
native reductase is isolated only after detergent solubilization (31, 32), 
whereas a smaller soluble form is produced by lysosomal proteases con-
taminating the microsomal fraction (33). Thus the reductase represents an 
amphipathic protein, like cytochrome b5• A physiological electron acceptor 
of cytochrome b 5 is the stearyl-CoA desaturase, which has been purified 
from rat microsomes (10, 34). It is a single polypeptide species of an 
apparent molecular weight of 53,000, which contains one iron atom. The 
desaturase is extracted only by detergents, and, accordingly, its amino acid 
composition shows an abundance of non polar amino acid residues. 
These three microsomal electron transfer components have been incorpo-
rated into liposomes or microsomal vesicles (29, 35-37), in order to recon-
stitute a partial or complete electron transfer system from NADH to the 
terminal desaturase, and to examine protein-protein, protein-lipid, and 
diffusion-dependent interactions. All three enzymes, in any combination, 
bind to vesicles that retain a spherical shape with a diameter of 250-400 
A.. It is found that the catalytic centers ofthe reductase, cytochrome b5 and 
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the desaturase are all oriented toward the outer surface of the small vesicles. 
Vesicles, containing the cytochrome bs and reductase, catalyze electron 
transfer (from NADH to cytochrome bs or to cytochrome c) at rates 
indistinguishable from those observed with microsomal preparations (35, 
36). The rate of electron transfer is dependent upon the surface concentra-
tion of the components in the bilayer. At low concentrations, flavin oxida-
tion by cytochrome bs becomes rate limiting, as expected for a reaction in 
which protein-protein interactions become diffusion-limited. This is consis-
tent with a model involving random distribution of the nonpolar segments 
of these proteins in the phospholipid bilayer, and subsequent movement of 
the molecules through a distance of several molecular diameters to achieve 
productive collisions. In the complete desaturase system (34), the hydrogen 
abstraction from the substrate is rate limiting. Thus the overall reaction is 
not diffusion limited. 
Recently, evidence has been presented that two forms of a soluble cyto-
chrome bs isolated from the supernatant of fresh bovine erythrocytes are 
identical to segments of microsomal cytochrome bs (38). Erythrocyte cyto-
chrome bs participates in the reduction of methemoglobin by transferring 
electrons from erythrocyte cytochrome bs reductase to methemoglobin (13, 
14, 39). Apart from being water soluble, erythrocyte cytochrome bs is very 
similar to the microsomal cytochrome. The visible and electron paramag-
netic resonance spectra of the two proteins are similar. Both forms of 
cytochrome bs can be reduced by the microsomal cytochrome bs reductase. 
Proteolysis by trypsin results in a hemoprotein indistinguishable from the 
tryptic products of the microsomal protein. These results agree with the 
hypothesis (39, 40) that soluble erythrocyte cytochrome bs is derived dur-
ing erythropoiesis by proteolytic degradation of the membrane-bound cyto-
chrome bs present in the endoplasmatic reticulum of the proerythroblasts. 
Such a conversion would imply that during differentation of a cell, different 
biological functions can be performed by a membrane-bound protein and 
the water-soluble catalytic segment of that protein. 
BACTERIAL b-CYTOCHROMES 
Escherichia Coli 
In Escherichia coli at least five b-type cytochromes have been identified 
which have been designated, according to their spectral properties, b-556, 
b-558, b-562, b-556 (NO-3), and cytochrome 0 (4, 41, 42). In principle, 
the E. coli system would appear to be especially attractive, as defined 
growth conditions can be used to induce or repress specific cytochrome b 
-requiring pathways. Furthermore, specific mutants may be obtained with 
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lesions in defined structural genes. Despite these potentialities of the E. coli 
system, definite information is, up to now, available only for b-562 and the 
b-556 of the nitrate reductase. 
CYTOCHROME b-562 a protein of about 12,000 molecular weight, is iso-
lated from a soluble extract of disrupted cells (43, 44). Significant amounts, 
however, have been detected in membrane particles (45). Its function and 
intracellular location are still unknown. The three dimensional structure 
has been determined to 2.5 A resolution (46). This b-type cytochrome has 
a methionyl and a histidyl residue as heme ligands, like cytochrome c. Its 
half-reduction potential of E m7 = +110 mY is rather positive, but it is lower 
than that ofa c-type cytochrome (Em7 ~ +230 -+270 mY). This may be 
attributed to the observation that in the cytochrome b-562 the heme is more 
exposed to the solvent than in cytochrome c (46). The structure of E. coli 
cytochrome b-562 represents a new type of cytochrome fold, and shows a 
differ(.nt topology from that of cytochrome b 5, cytochrome c, or the glob-
ins. 
CYTOCHROME b-556 OF NITRATE REDUCTASE The ubiquinol : nitrate 
reductase has been isolated from E. coli (47-51). The multisubunit complex 
contains cytochrome b-556 (N03-) as a subunit. As yet, the b-type cyto-
chrome itself has not been purified. The nitrate reductase constitutes the 
terminal part of an anaerobic electron pathway localized in the bacterial 
plasma membrane (see Figure 2). This enzyme system has received special 
attention during the past years, since the electron transfer from QH2 to 
nitrate is coupled to the formation of a transmembrane proton gradient. 
The QH2 : nitrate reductase was isolated by several laboratories after 
solubilization with detergent (47-51), and was found to contain three differ-
ent polypeptide subunits of apparent molecular weights of 155,000, 63,000, 
and 19,000. Reductase preparations solubilized from the membrane by 
alkaline heat treatment lack spectral cytochrome b and also the 19,000-
dalton subunit (51-54). Thus it was concluded, that the 19,OOO-dalton 
subunit represents the apoprotein of cytochrome b-556 (N03-). Further 
- - + 
HCOO)+ H2:ormate nitrat:03 (+ 2H 
: dehydrogenase __ cyt. b __ quinone __ cyt. b __ reductase : 
(Se,Mo,Fe/S) (Mo,Fe/S) 
- + -HC0 3 + 2H N02 + H20 
Figure 2 Scheme of the electron pathway from formate to nitrate in Escherichia coli (47,64). 
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redox centres such as molybdenum (52, 54, 55) and nonheme iron (54, 56) 
were found to be present in the two larger subunits. The spectrum of 
cytochrome b-556 (N03 -) shows absorbance maxima at 559 nm, 531 nm, 
and 428 nm when it is integrated in the isolated nitrate reductase complex 
(47, 48). The molar ratio of the cytochrome in the complex is not clear. 
Heme contents of 6.7 (47, 48) and 15 (50) nmollmg nitrate reductase have 
been reported. From the amount of the 19,000-dalton apoprotein present 
in the whole complex, ratios of 1 : 1 : 2 for the subunits of molecular weights 
155,000, 63,000, and 19,000 have been calculated (49, 57). 
The nitrate reductase is induced only in anaerobically grown cells in the 
presence of nitrate and molybdenum [see e.g. (42, 58, 59)]. The fully in-
duced enzyme protein constitutes up to 15% of the cytoplasmic membrane 
(49, 50). Concomitant with the reductase activity the b-type cytochrome is 
formed. A heme-deficient mutant unable to synthesize S-aminolevulinic 
acid, produces reduced amounts of membrane-bound reductase which con-
tain no cytochrome b subunit. A large amount of a soluble form of the 
two-subunit reductase accumulates in the cytoplasm of this mutant (57,60). 
When S-aminolevulinic acid is added to the mutant culture, the cytoplasmic 
form of the enzyme is incorporated into the membrane in a stable form 
coincident with the formation of functional cytochrome b (60). These re-
sults indicate that a complex of the two large subunits binds to the mem-
brane upon interaction with the third subunit, cytochrome b. 
The cytochrome b appears to be functionally involved in the QH2 : nitrate 
reductase reaction. The complete reaction is obtained with the cytochrome 
b--containing preparation, whereas in a cytochrome-free reductase, nitrate 
can only be reduced with artificial electron donors (57). The cytochrome 
b can be reduced by formate in the presence of E. coli formate dehydroge-
nase (47). The reduced cytochrome of the reductase is immediately reoxi-
dized upon addition of nitrate. The whole formate: nitrate reductase 
reaction was reconstituted using the soluble purified formate dehydrogenase 
and the nitrate reductase. The rate of the reaction was stimulated 33-fold 
by the addition of ubiquinone-6. A cytochrome b-free preparation of the 
reductase was completely inactive in the reconstituted system. The b-type 
cytochrome of the formate dehydrogenase appears to be different from that 
of the reductase (48), although the molecular weights are similar and the 
spectral properties are indistinguishable. 
Surface-labelling experiments with membrane-nonpermeating probes in-
dicate that the cytochrome b apoprotein is accessible from the J!<!riplasmic 
face of the cytoplasmic membrane, whereas the 155,000-dalton subunit is 
accessible from the cytoplasmic side (61,62). This transmembrane location 
of the QH2: nitrate reductase system of E. coli is further indicated by studies 
with membrane-permeating and nonpermeating substrates (63,64). It has 
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been emphasized that the proton translocation produced during the elec-
tron flow from QH2 to nitrate is chemiosmotic. The electron-translocating 
oxidoreduction connects a proton-consuming and a proton-producing half 
reaction which occur on opposite sides of the membrane according to 
following reactions: 
1. 
2. 
NO-
3 
+ QH2 + 2H: __ NO-2 + Q + H20 + 2H+ m out 3. 
QH2 most likely reacts directly with cytochrome b located at the periplas-
mic side of the membrane (Reaction 1), since the nonpermeant Diquat 
radical (DQ+) is an excellent reductant for nitrate reductase in spheroplasts 
provided that the cytochrome b of the complex is present (63). Absence of 
ubiquinone or menaquinone, as in double quinone mutant, does not alter 
the ability of DQ+ to reduce nitrate reductase. The immediate source of the 
protons and electrons for nitrate reduction (Reaction 2) is on the cytoplas-
mic side of the membrane. The access of nitrate to the active site, however, 
is still unclear. The permeation of nitrate across the membrane is too slow 
to be kinetically competent for the nitrate reduction rate. It has been 
suggested that nitrate approaches the electron- and proton-donating redox 
centre via a cleft extending inwards from the periplasmic surface (64). 
Vibrio Succinogenes 
Vibrio succinogenes, an anaerobic bacterium, contains two b-type cyto-
chromes in the cytoplasmic membrane, which participate in the electron 
transfer from formate to fumarate (Figure 3). They have a common absorb-
ance spectrum with an absorbance maximum at 562 nm in the dithionite-
reduced state, but they possess quite different half-reduction potentials. The 
electron transport from formate to fumarate is associated with the genera-
tion of an electrochemical proton gradient across the cytoplasmic mem-
brane of the bacterium, and with the phosphorylation of ADP. 
The fumarate reductase complex, the terminal part of the electron-trans-
ferring chain from formate to fumarate, has been extracted from the cyto-
plasmic membrane with Triton X-lOO and purified by means of 
chromatography oh hydroxyapatite and DEAE Sephadex (65). It consists 
of three polypeptide subunits of apparent molecular weights of 79,000, 
31,000, and 25,000. A complex lacking the heme b absorbance signal has 
been isolated (65). It did not contain the 25,000-dalton subunit. Therefore 
cytochrome b has been attributed to the 25,000-dalton polypeptide. The 
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- + HCOO + H20 fumarate + 2H 
) 
formate t b t b fumarate ( 
: dehydrogenase --( :~oo V) __ menaquinone ~ :~O· V) ~reductase : 
(Mo,Fe/S) m m (FAD,Fe/S) 
- + HC0 3 + 2H succinate 
Figure 3 Scheme of the electron pathway from formate to fumarate in Vibrio succinogenes 
(68). 
FAD has been found exclusively in the 79,000-molecular weight peptide. 
Nonheme iron and acid-labile sulfide were found in the 79,000 and 31,000-
dalton polypeptides. A molar ratio of 1 : 1 : 2 in the complete complex for 
the subunits of molecular weight 79,000: 31,000: 25,000 has been calcu-
lated. 
The enzyme catalyzed three types of reactions: (0) Fumarate reduction, 
by viologen radicals or anthrahydroquinone sulfonate, which was indepen-
dent of the presence of cytochrome b and insensitive to p-chloromer-
curiphenyl sulfonate (P-CMS); (b) succinate oxidation by ferricyanide, 
Methylene Blue, or phenazine methosulfate, which also was independent of 
cytochrome b, but sensitive to p-CMS; and (c) fumarate reduction by 
certain naphthohydroquinones, and a succinate oxidation by certain qui-
nones. Both of the latter activities were dependent on the presence of 
cytochrome b and sensitive to p-CMS. It has been concluded that, in the 
membrane of the bacterium, cytochrome b (E m7 = -20 m V) is the primary 
acceptor of the electrons of menahydroquinone, and the donor for the 
iron-sulfur centres of the fumarate reductase (see Figure 3). 
The formate dehydrogenase complex, the upper part of the electron-
transferring chain from formate to fumarate, has been extracted from the 
cytoplasmic membrane with Triton X-lOO and enriched by means of hy-
droxyapatite and DEAE Sephadex chromatography, and sucrose-density-
gradient centrifugation (66). It consists of two polypeptide subunits of 
apparent molecular weights 110,000 and 25,000. The large subunit contains 
molybdenum, nonheme iron, and acid-labile sulfide; the smaller subunit 
carries the heme IX. The complex consists of two moles of the large subunit 
and varying amount of the small subunit, i.e. cytochrome b. The authors 
are not yet certain whether this cytochrome b belongs to the formate 
dehydrogenase complex. They speculate that either the extent of dissocia-
tion or co-isolation may vary with different preparations. The cytochrome 
b has a half-reduction potential of Em7 = -200 mY. It can be reduced by 
formate. The electron transfer from formate to menaquinone has been 
inhibited by 2-(n-nonyl)-4-hydroxyquinoline-N-oxide (NOHOQnO). The 
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half-reduction potential of cytochrome b shifted from -200 m V to -240 m V 
under these conditions. It has been concluded that in the membrane of the 
bacterium this cytochrome b is the direct electron donor for menaquinone, 
and that the inhibition of electron transfer from formate to menaquinone 
by NOHOQnO is caused by the binding of the inhibitor directly to this 
cytochrome b (see Figure 3). 
The position of the two b-type cytochromes has been confirmed by 
quinone-extraction experiments (67). The oxidation of cytochrome b (-200 
m V) by fumarate is inhibited by the extraction of menaquinone, whereas the 
reduction by formate is unaffected. In contrast, the reduction of cytochrome 
b (-200mV) by formate, but not the oxidation by fumarate, is dependent 
on the presence of menaquinone. 
From accessibility studies with membrane-permeating and nonpermeat-
ing dyes it has been concluded that the active site of formate dehydrogenase 
faces the periplasmatic space, while that of fumarate reductase is in contact 
with the cytoplasm of the bacterium (68). Thus it has been speculated that, 
possibly, in V. succinogenes only electrons, and not protons, may be tran-
slocated across the membrane, since the two protolytic half-reactions on 
opposite sides of the membrane are capable of creating a proton gradient. 
Protons are liberated on the outside by the reaction of formate dehydroge-
nase with formate, and are taken up on the inside by the reaction of 
fumarate reductase with fumarate. As this mechanism accounts for the 
observed H+ le ratio, there would be no need for proton translocation by 
menaquinone. 
The operation ofmenaquinone as H+ translocator, however, has not been 
excluded. In preliminary experiments H+ liberation during fumarate oxida-
tion has been measured with cell suspensions of V. succinogenes with a ratio 
of H+ 12e = 1.1-1.3 (69). However, proton gradient measurements with 
these bacteria are still technically complicated. With current techniques, the 
data are not reliable enough to give exact H+ 12e ratios, which would help 
to prove or disprove the existence of an ubiquinone-linked proton transport. 
With spheroplasts grown on formate and fumarate, P /2e ratios of 0.4--1 
have been measured (69). These experiments give, however, no information 
about the mechanism of the proton gradient creation. 
MITOCHONDRIAL b-CYTOCHROMES 
Introduction 
b-type cytochromes are constituents of two different multi protein com-
plexes of the mitochondrial respiratory chain. About 80% of the total 
cytochrome b is a component polypeptide of the ubiquinol: cytochrome c 
reductase (also named complex Ill), and about 20% is an integral part of 
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the succinate: ubiquinone reductase, the so-called complex 11. Both com-
plexes seem to form discrete structural and functional units of the mito-
chondrial inner membrane (70). The complexes have been isolated from the 
membrane by quite different methods; independent of the applied isolation 
procedure they contained the same number of polypeptide subunits, pos-
sessing distinct molecular weights and functional characteristics (71). Com-
plex III consists of 8 subunits (72), complex 11 of only 4 (73). Cytochrome 
b of complex III has deserved special interest, since it is intimately involved 
in the energy conversion process at the second phosphorylation site (74). 
The function of the cytochrome b of complex 11 is still dubious (75). It 
remains to be established whether it is involved in the main path of electron 
flow from succinate to ubiquinone, or whether it represents a redox compo-
nent of a specific metabolic pathway. 
Complex III spans the mitochondrial membrane. Some of its polypep-
tides are placed nearer the surface of the membrane, for instance cyto-
chrome c" or the iron-sulfur protein; some polypeptides (e.g. cytochrome 
b) seem to be buried more in the core of the protein architecture (76). 
The discussion of cytochrome b function is complicated because, quite 
apart from other unsolved questions, even its arrangement in the sequence 
of the electron-transferring components is under discussion (7, 77). The 
complexity of the problems increases as one goes from studies on the 
resolved cytochrome b to studies of cytochrome b integrated in mem-
branes. Therefore, the properties and function of cytochrome b is discussed 
in the following order:( a) isolated cytochrome b, (b) cytochrome b in 
complexes, and finally (c) cytochrome b in situ. 
Cytochrome b of the Ubiquinol: Cytochrome c Reductase 
ISOLATED CYTOCHROME b The various preparations of cytochrome b 
are described with the aid of Table l. The preparations from beef heart 
mitochondria are compiled in chronological order. Already in 1961 a highly 
purified cytochrome b was obtained (78). As in all subsequent procedures, 
a detergent in the presence of high salt concentrations had to be used in 
order to solubilize the membranous structure, and to hold the hydrophobic 
polypeptides in a solubilized state. With the exception of preparation (d) 
[see Table I (79)] bile salts were used as detergent during solubilization and 
isolation; for the subsequent separation of the cytochrome b a series of 
ammonium sulfate precipitations were applied. In preparation (d) and (e) 
(80) precipitation reactions were avoided. In case (d) the beef heart cyto-
chrome b was prepared by a series of hydroxyapatite chromatographic 
treatments in the presence of Triton X-lOO. The starting material was a pure 
antimycin-loaded be 1 complex, which was dissociated by guanidine plus 
Triton X-lOO. The Neurospora cytochrome b(e) was prepared by chroma-
Table I Isolation methods and properties of resolved cytochrome b of complex 1II IV 
\0 
Molecular weight based on: 
~ 
Heme Dodecyl-
Isolation content sulfate <: Starting (I'mol/g Heme electra- Absorbance Em7 0 
Source Solubilization Fractionation material protein) content phoresis Ultracentrifugation maxima (mV) Comments Z 
..... 
(a) Beef heart Deoxycholate Cholate/ammo- Mitochondria 36 28,000 S20,w = 2.6 in 562.5, -340 Denaturation > 
(78) KCI nium sulfate, cetyldimethylam- 532.5, by SDS g 
dodecylsulfate monium bromide 429 ~ (b) Beef heart Cholate/ Cholate/ammo- "Green Brei" 47 21,000 Aggregation 561.5, -21 Cleavage of p,.. (82) ammonium nium sulfate, of mitochon- 531, apoprotein 
,ulfate protease, Ema- dria 428.5 by protease 00 t!1 
sol, DEAE t:C 
cellulose > t"'" (c) Beef heart Cholate/ Dodecylsulfate, Succinate: 38,000 38,000 560, I::) 
(83) ammonium ammonium cytochrome 530, 
sulfate sulfate, Sepha- c reductase 427 
dex GI50 
(d) Beef heart Triton X-lOO, Triton X-lOO, Cytochrome 30 33,000 31,000 62,000 from sedi- 560, -5 Dimeric 
(79) Pi, NaCI guanidinium bel complex mentation equili- 525, -85 structure 
chloride hy- loaded with brium in Triton 427 
droxyapatite antimycin X-lOO 
chromato-
graphy 
(e) Neurospora Cholate, Deoxvcholate, Submito- 35 30,000 32,000 51,000 from sedi- 561, -70 Dimeric 
crassa deoxycholate Lubrol,oleyl- chondrial mentation equili- 530, structure 
(80,81) polymethacry- particles brium in bile salts 429 
lie acid resin 
chromato-
graphy 
(I) Yeast Deoxycholate. Cholate, deoxy- Submito- 2.8 28,000 Aggregation 562, Loss of 
(84) KCl cholate, ammo- chondrial 532, heme b 
nium sulfate. particles 430 
protease, 
Tween 80 
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tography on oleyl-polymethacrylic acid resin, with subsequent chromatog-
raphy on DEAE cellulose and a recycling gel filtration on Sephadex G-75. 
Sources (d) and (e) have provided good evidence for a 30,000 molecular 
weight of the monomeric cytochrome b, based on pyridine hemochromogen 
contents, and on gel electrophoresis and gel chromatography in the pres-
ence of dodecylsulfate (79, 81). The same molecular weight was already 
found for preparation (a). The molecular weight of 21,000 of preparation 
(b) (82) may be due to the cleavage of a 9.000-dalton polypeptide from 
cytochrome b due to application of a protease during isolation. The high 
molecular weight of preparation (c) (83) may be caused by special condi-
tions during dodecylsulfate electrophoresis. The yeast preparation lost a 
major part of its heme b during isolation (84). 
The absorbance spectra of the various preparations are very similar. The 
a-absorbance maxima of the absolute spectra of ferro-cytochrome b lie at 
560-562 nm, those of the ,B-bands at 525-532.5 nm, and those of the Soret 
bands at 427-430 nm. The redox potentials of the heme b centers seem to 
be a more sensitive parameter for the functional state of the isolated cyto-
chrome b than the absorbance spectra. Preparation (a) in which high 
concentrations of the denaturing detergent sodium dodecylsulfate were 
used during isolation, reveals the most negative half-reduction potential 
(-340 m V). The value has to be taken cautiously because only redox equilib-
rium studies with xanthine: hypoxanthine as redox couple, and benzyl vi-
ologen as redox mediator were undertaken over a small potential range (85). 
The same holds for titration of preparation (b) in which redox equilibrium 
was achieved with the ferri : ferro oxalate couple (86). The first potentiomet-
ric redox titrations were performed on the Neurospora preparation (G. von 
Jagow, unpublished results). The heme centers showed a unique potential 
of -70mV. The two different redox potentials and the more complex redox 
behavior of the heme centers of preparation (d) are discussed at the end of 
the section. 
The amino acid composition of the beef heart preparation (c) and (d) are 
comparable. Both preparations have a low content of lysine and arginine, 
and a high content of nonpolar amino acids, especially leucine and isoleu-
cine. From these results a low polarity (88) of 0.32 was calculated, charac-
teristic for an integral membrane protein. It is noteworthy that the amino 
acid composition and the polarity (0.37) (88) of the Neurospora preparation 
are similar to that of beef heart preparations (81). 
The isolated cytochrome b has been found to be a dimer. This correlates 
with the occurrence oftwo cytochromes b per complex Ill. The first indica-
tion for the existence of a dimeric protein came from gel chromatographic, 
electrophoretic, and ultracentrifugal studies carried out with Neurospora 
cytochrome b (80, 89). It exhibited a molecular weight of 55,000 in a 
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Sephadex G-75 chromatography performed in a bile salt plus KCI medium, 
while, in contrast, a molecular weight of 30,000 was found using dodecylsul-
fate gel electrophoresis. In hydrodynamic studies carried out in the presence 
of deoxycholate, values of s20,w = 4.2, and D20,w = 6.3 were obtained, from 
which a molecular weight of 63,000 was calculated (90). Sedimentation 
equilibrium studies led to the calculation of a molecular weight of 51,000 
after correction for the bound detergent (0.3 g deoxycholate per gram of 
protein). A dimeric-isolated cytochrome b has also been demonstrated for 
beef heart preparation (d) (79). In contrast to the Neurospora preparation, 
the protein was kept in the resolved state during ultracentrifugation by 
Triton X-lOO instead of deoxycholate. In equilibrium studies the prepara-
tion equilibrated with a molecular weight of 150,000. After correction for 
the bound detergent a molecular weight of 62,000 was calculated for the 
protein moiety. From experiments with 3H-Triton X-lOO a specific binding 
of 1.5 g Triton X-lOO per gram of protein was calculated. This value 
corresponds to the binding of one Triton micelle per mole of dimeric 
cytochrome b, assuming a molecular weight of 90,000 for the Triton micelle 
(91). 
It soon became an intriguing question, whether the dimeric cytochrome 
b represents a homo- or a hetero-dimer, especially since the existence of two 
functionally different cytochromes b in complex III has generally been 
postulated on the basis of many spectral, kinetic, and potentiometric data, 
obtained from studies on cytochrome b integrated in the mitochondrial 
membrane, or in the isolated complex III (see below) (77, 92). In early 
experiments the Neurospora cytochrome b was eluted in two separate 
fractions after hydroxyapatite chromatography in the presence of dodecyl-
sulfate (93). It could not, however, be convincingly shown that the two 
fractions represented two different cytochrome polypeptides. Partial amino 
acid sequences of the proteins from Neurospora and beef heart, including 
the C- and N-terminal ends, showed only one unique sequence (79, 93). 
Genetic experiments described below indicate the existence of only one 
structural gene for the cytochrome b apoprotein. Thus the experimental 
data available at present strongly suggest the existence of two structurally 
identical subunits in the cytochrome b dimer. The possibility can not be 
excluded, however, that minor differences between the two subunits may 
exist, which may originate from a post-translational modification. 
A further question concerns the functional state of the isolated cyto-
chrome b dimer, i.e. the extent of preservation of the native conformation. 
The spectral properties of cytochrome b change during isolation. The ab-
sorbance maximum of the a-band of the dithionite-reduced cytochrome b 
is shifted to shorter wavelength. The splitting of the a-bands of the Neuros-
pora cytochrome b, which can be obtained at -196°C with the complex-
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bound species, is lost with the isolated cytochrome (90). Unlike cytochrome 
b in situ, all isolated preparations so far react with the unphysiological 
ligands carbon monoxide and oxygen. It could well be that structural 
alterations are caused by the detergents, and/or the chaotripic agents ap-
plied during isolation, but it could also be visualized that the native confor-
mation of the b-cytochrome depends on the association of other subunits 
of complex Ill. It cannot be decided whether the preparations of isolated 
cytochrome b are still able to carry out a physiological electron transfer 
reaction, since an assay for this partial reaction is not yet available. 
In the case of cytochrome b of beef heart [Table 1, (d)] some functional 
conformation seems to be preserved, as indicated by the existence of two 
different half-reduction potentials (79, 94). They amount to E m7 = -5 m V, 
and Em7' = -85 mY. The values are shifted by only 40 mV to the negative 
as compared to cytochrome b in situ (95). Moreover, both potentials show 
a pH dependence. As soon as the pH is raised from 7.0 to 8.0, both centers 
change their redox potential by about 40 m V to the negative, i.e. the redox 
change involves a protonation reaction according to the following reaction: 
cyt.bHR + e- + H+ ~ cyt.bHRH 
The abbreviation R in the equation represents an amino acid residue, which 
undergoes a protonation : deprotonation reaction. Combining this reaction 
with the Nemst equation, a complete protonation: deprotonation should 
result in a pH -dependence of 60 m V/unit pH (96). A value of only 40 m V 
may indicate a change of pkR due to some conformational changes of the 
isolated dimer. But the pH-dependence may justify the hypothesis that 
cytochrome b is a likely candidate for a proton-pumping device at the 
second phosphorylation site, as is discussed below (94). 
CYTOCHROME b OF THE RESOLVED UBIQUINOL:CYTOCHROME c 
REDUCTASE The cytochrome b is a building stone of complex Ill, and 
its function is intimately interconnected with the function of the other 
subunits. Thus the properties of cytochrome b have to be described in the 
context of the electron transfer and the energy-transducing reactions per-
formed by the whole complex. Pure complex III preparations have been 
obtained from several organisms, which allows an analysis of the specific 
properties of this enzyme system without interference of the other com-
plexes of the respiratory chain. 
Several methods have been developed for isolation of complex III by 
ammonium salt fractionation of membrane proteins that have been previ-
ously solubilized by bile acids in the presence of high salt concentrations. 
Of these, in Table 2, only methods (a) (97) and (b) (98) for beef heart, and 
(e) (99) and (j) (100) for yeast mitochondria are cited. Apparently, all these 
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preparations are obtained in a highly aggregated state. The heme b content 
of the complexes varies between 8 and 9 /Lmol per gram of protein. Conse-
quently, the minimum molecular weights of the multienzyme complexes 
were calculated as being within the range of 200,000-250,000. Preparations 
(c) (101) and (d) (102, 103) were isolated by chromatography with Triton 
X-lOO, the beef heart complex by a hydroxyapatite chromatography, and 
the Neurospora complex by affinity chromatography on immobilized cyto-
chrome c. 
The aggregation states of the complexes (c) and (d) (Table 2) were 
investigated by ultracentrifugal studies (103, 104). From sedimentation 
velocity and equilibrium runs performed with the beef heart preparation, 
it was concluded that the isolated complex is present exclusively in a dim-
eric aggregation state. A molecular weight of 400,000 was calculated after 
correction for the bound detergent. This was in contrast to a calculated 
minimum molecular weight of 200,000 based on the heme band c I contents 
(pyridine hemochromogens), and on summing up the molecular weights of 
the single subunits. One dimeric complex was held in solution by the specific 
binding ofO.2 g Triton X-lOO per gram of protein. This amount is equiva-
lent to the molecular weight of one Triton micelle (91). A dimeric complex 
and the same amount of specifically bound Triton were found for the 
Neurospora preparation (103). Two-dimensional crystals could be formed 
with this dimeric complex (105). The diffraction patterns and the optically 
filtered image of the electron micrographs were interpreted to show that 
alternate protein molecules are arranged in an up and down manner. The 
dimensions of one of these dimeric cytochrome c reductase molecules in 
projection are about 90 A X 70 A, which is consistent with the estimated 
Stokes radius and molecular weight of the dimeric enzyme protein, as well 
as the strict vectorial orientation of the complex in the membrane (106). 
All preparations summarized in Table 2 contain, according to gel electro-
phoretic analysis, the same number of polypeptides, with the exception of 
preparation (c), which is devoid of the iron-sulfur protein due to application 
of antimycin during isolation (107). The mean values of the molecular 
weights of the subunits are in general agreement (72), and amount to about 
48,000, 45,000, 30,000, 29,000, 25,000, 12,000, 10,000, and 5,000 (108). A 
specific adaption of the dodecylsulfate gel electrophoresis leads to a further 
resolution of the low-molecular-weight fractions. Three additional small 
polypeptides can be detected (99). The two largest polypeptides-named 
core protein 1 and 2-possess no redox centers (109). The 30,000--29,000-
dalton polypeptide band encloses the apoprotein of cytochrome b and the 
cytochrome Cl molecule, which are not regularly separated (80, 110). The 
25.000-dalton subunit represents the apoprotein of the iron-sulfur protein, 
which is a ferredoxin-type enzyme containing, in the native state, 2 non-
Table 2 Isolation methods and properties of complex JIl 
Mulecular weight 
Heme b based on: Number of Cytochrome [nzymatic Isolation ().Imol/g Heme Ultra- poly- b absorbance Em7 activity 
Source Solubilization fractionation protein) content centrifugation pep tides maxima (mY) (units/mg) Comments 
(a) Beef heart Cholate/ (,holate, deoxy- 250,000 SW,w = 10.2 562,565 +90 mY, 1,000 Highest enzy-
(97) ammonium cholate/ammo- in tauro- -34 mY matic activity 
sulfate nium sulfate cholate 
(b) Beef heart Cholate/ Deoxychola te, 6.5 307,000 562 for both 28 
(98) ammonium ammonium together 
sulfate sulfate, NaOH 
(c) Beef heart Triton X-lOO, Triton X-lOO, 200,000 400,000 from 6 559,561 +80 mY, none Devoid of 
(101) ammonium hydroxyapatite sedimentation -10 mY nonheme iron 
sulfate chromatography equilibrium protein; anti-
mycin bound; <:r-
.:., 
isolated as ~ dimer '"d 
(d) Neurospora Triton X-lOO, Triton X-lOO, 550,000 from Isolated as m (') 
crassa Pi affinity sedimentation dimer ~ (102,103) chromatography equilibrium ..., 
(e) Yeast Deoxycholate, Cholate/ammo- 250,000 561 for both 20 0 (') 
(99) KCI nium sulfate together ::I: 
(j) Yeast Cholate/ Deoxycholate/ 9 200,000 7-8 562 for both 108 ~ 0 (100) ammonium ammonium together ~ sulfate sulfate, Triton m 
X-lOO Vl 
N 
\Cl 
\Cl 
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heme iron atoms, and 2 acid labile sulfide atoms (77, 111). Nothing is 
known about the function of the smaller polypeptides. The 1O.000-dalton 
polypeptide subunit was suggested to carry an antimycin-binding site, but 
this assignment is still under discussion (77, 112). All preparations except 
(c) contain two heme b, one heme C (cytochrome Cl), and one Fe2S2 center 
per mole of monomeric complex. If a one to one stoichiometry of the single 
polypeptides is assumed, those polypeptides that carry no redox center 
amount to half of the molecular weight of the whole complex. Their exis-
tence was explained by a kind of "structural pillow function," but they 
could be involved also in reactions enabling an electrogenic proton transfer. 
Some preliminary results concerning the architecture of the complex 
have been obtained with the Neurospora complex. The multiprotein unit 
could be cleaved into definite subcomplexes using increasing salt and deter-
gent concentrations (102). The Neurospora complex is especially suited for 
such experiments, since the protein-protein interactions are weaker than in 
the beef heart complex. The first dissociated polypeptide, which was cleaved 
off already during certain preparation conditions, was the iron-sulfur pro-
tein (102). Subsequently, the two core proteins were dissociated under 
relatively mild conditions leading to a second subcomplex. A further dis-
sociation yielded the dimeric cytochrome b and cytochrome C I associated 
with a smaller subunit. From these experiments it has been concluded, in 
contrast to the cross-linking and surface labelling studies described below, 
that the core proteins are arranged on the matrix surface of the mitochon-
drial inner membrane (113). 
Surface labelling studies with isolated complex Ill, and complex III 
incorporated into phosphOlipid vesicles from beef heart, gave a uniform 
incorporation of radioactivity in all subunits except the smallest one (114). 
In contrast, cytochrome b from Neurospora integrated into the mitochon-
drial membrane was almost inaccessible to such a probe (93). Recent cross-
linking and surface labelling studies gave additional information on the 
orientation of the polypeptides in the beef heart complex (106, 115). In these 
experiments all nine different component polypeptide subunits were labelled 
when the complex was present in isolated form; but in mitochondria the two 
core proteins, cytochrome b, cytochrome Cl, the nonheme iron protein, and 
only two of the smaller polypeptides (VI and VII) were tagged from the 
cytosolic side. In submitochondrial particles, cytochrome b and core pro-
tein 2 were exclusively accessible from the matrix side. The experiments 
suggest a model for the arrangement of the polypeptides (106) as depicted 
in Figure 4. Cytochrome b and core protein 2 span the mitochrondial 
membrane. Cytochrome C I is placed on the cytosolic side less peripherally 
than the small subunit VI. The two small polypeptides VIII and IX seem 
to be buried in the membrane, since they were not labelled from either side 
of the membrane. They are not shown in the scheme of Figure 4. 
matrix side 
core 2 
core 1 '\, ... 
Fe/S 
I 
I 
,,''''-
I I 
cytosolic 
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b dimer 
small 
polypeptides 
Figure 4 Model for the arrangement of the subunits of complex III based on surface labeling 
and cross-linking experiments [after (106)]. The cross-linking products are indicated by "ties" 
between the respective subunits. 
The orientation of the chromophores of the complex could be determined 
in hydrated oriented multilayers of reconstituted proteoliposomes using 
optical and EPR spectroscopy (116). The hemes of cytochromes band 
cytochrome Cl are oriented parallel to each other, and perpendicular to the 
plane of the membrane. The iron-sulfur centre of the nonheme iron protein 
is oriented with the z-axis of the g-tensor parallel to the plane of the 
membrane, i.e. this center is also oriented parallel to the planes of the heme 
centers. Obviously the asymmetry of the complex led to an oriented incor-
poration of the complex in the lipid bilayer. 
The two heme b centers of the complex possess distinct redox potentials 
as in situ and in the isolated cytochrome b dimer. Moreover, the two heme 
b centers of the resolved complex have preserved two different absorption 
spectra, as in situ. This contrasts to those of the resolved b dimer where 
this property has been lost. In the beef heart complex about one half of b 
can be reduced by ubiquinol or ascorbate plus TMPD, the further half only 
by dithionite. In preparation (a) the first part has an absorbance maximum 
at 562 nm, the second one at 565 nm (117). In preparation (c) the absorb-
ance maxima are shifted 3 nm to the blue (tol). This preparation differs 
from preparation (a) in having lost the iron-sulfur protein (as described 
above), and having a lower phospholipid content. The heme b centers of 
the complex do not react with carbon monoxide or oxygen as they did in 
the isolated dimer, probably because they are better protected in the core 
of the protein complex. 
The task of the complex within the respiratory chain is to accept electrons 
from the ubiquinone-to pool, and to transfer them eventually to cyto-
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chrome c. Simultaneously the combustion energy has to be transferred into 
an energy form suitable for ATP synthesis. A present-day description of the 
function of cytochrome b in these processes can only be vague. In the 
literature, numerous hypothetical schemes are given for the pathway of the 
electrons (118). The following preliminary scheme (Figure 5) is offered for 
the arrangement of the electron carriers in complex Ill. The b cytochromes 
have been arranged in series, in parallel, and in other ways. The actual 
arrangement is yet unknown. The presumptive direct electron donor of the 
b cytochromes is ubiquinone-lO (119, 120). One hypothesis suggests that 
the b cytochromes transfer the electrons to a second ubiquinone-lO pool, 
as is discussed below (121). According to another version of the electron 
transport chain, cytochromes b transfer the electrons directly to the iron-
sulfur center of the nonheme iron protein. The latter component seems to 
be inserted between cytochromes band c \. Recent experiments suggest that 
the intimate electron acceptor of cytochromes b may be the iron-sulfur 
protein. The so-called oxidation factor was identified as the iron-sulfur 
protein of complex III (122). It could be shown that this redox component 
is obligatory for electron flow from succinate to cytochrome c in a prepara-
tion containing complex III and 11. Electron flow from succinate to cyto-
chrome c only occurred when the iron-sulfur protein was present in the 
preparation. In the absence of the iron-sulfur protein only cytochrome b 
was reduced by succinate, but not cytochrome c\ (123). 
The electron acceptor of cytochrome c \ is cytochrome c. It binds exclu-
sively to the cytochrome c \ subunit of the complex. In recent experiments 
it could be demonstrated, that the same surface area of cytochrome c was 
shielded during its binding, independent of whether it was bound to the 
whole complex or to isolated cytochrome c\ (124). It did not bind to 
isolated cytochrome b. 
In mitochondria, ubiquinone-lO is the electron donor for the complex. 
However, it cannot be used in the cuvette due to its high insolubility. 
Usually the ubiquinone analogues Q-2, or Q-3, are used, or analogues with 
an alkyl side chain instead of an isoprenyl side chain (125). As summarized 
in Table 2, the specific activities of Q-oxidation of the various complexes 
vary distinctly. This may be caused, among other things, by the partition 
coefficients of different Q analogues, as has been discussed in detail else-
where (126). 
cyt.b 
Q~ ~(Q)~Fe/S~cyt.cl~cyt.c 
cyt.b 
Figure 5 Preliminary scheme for the arrangement of the electron carriers in complex Ill. 
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The most potent inhibitor of the electron transferring capability of com-
plex III is the antibiotic antimycin (127). It inhibits the electron transfer 
from cytochrome b to cytochrome c \0 and prevents the cleavage of the 
complex into its subunits by cholate plus salt (128). The cytochrome c 
reductase activity is blocked with a linear dependence on inhibitor concen-
tration (129). When antimycin is bound to the complex its fluorescense is 
quenched (130). Studies of fluorescence quenching revealed one antimycin 
binding site per mole of complex (131). The same result was obtained from 
binding studies with pH]antimycin (132). The oxidized complex binds 
antimycin more firmly (kd = 1 X 10-13 M) than the succinate reduced one 
(kd = 6 X 10-" M) (127). The decrease in binding affinity was interpreted 
as occurring due to a conformational change of cytochrome b induced by 
the reduction of the heme b-562 center by succinate. 
A remarkable effect of antimycin on the redox centers of cytochromes 
b of the complex is the so-called antimycin-oxidant induced extra reduction 
(133). This steady-state phenomenon occurs during an antimycin-inhibited 
state when the electron transfer from cytochrome b to cytochrome c, is not 
completely blocked. Ubiquinol serving as electron donor reduces cyto-
chrome b to 30%, and cytochrome c, completely. An increase of cyto-
chrome b reduction to 90% takes place when cytochrome c, is oxidized, 
for instance by aid offerricyanide. The whole cycle of reactions is reversible, 
i.e. when ferricyanide becomes reduced, cytochrome c, becomes reduced, 
and consequently the degree of reduction of cytochrome b declines to the 
original value of 30%. The effect was interpreted by three mechanisms that 
differ in principal: 1. a transient increase of the half-reduction potential of 
cytochrome b induced cooperatively by a second unknown redox compo-
nent X, which is in redox equilibrium with cytochrome c, (133); 2. a 
transient increase of the half-reduction potential of cytochrome b due to its 
transition in an energized configuration, as long as electron flow occurs 
(134, 135); and 3. no increase of the half-reduction potential (E m7) of 
cytochrome b, but a decrease of the overall redox potential (Eh) due to a 
change of the QHo radical concentration during electron flow (136). In the 
authors opinion the described phenomenon reflects conformational interac-
tion between the redox components, but an exact interpretation of the 
reactions is not possible at the present state of knowledge. For instance, 
circular dichroism studies of the isolated complex from Saccharomyces 
cerevisiae revealed complex conformational interactions between cyto-
chromes band c, (137). In recent studies specific conformational altera-
tions of cytochromes b of this complex by uncouplers have been detected 
that seem to promise new insights for the further understanding of uncou-
pIer action (138). 
In order to study electrogenic proton transfer, the complex was incorpo-
rated into phospholipid vesicles by the cholate dialysis method (139). An 
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electron flow from ubiquinol 2 to cytochrome c served as source of energy. 
Both the reductant and the oxidant were added to the vesicles from outside. 
In the presence of valinomycin plus potassium the redox reaction was 
coupled to an outward translocation and outside liberation of protons. A 
stoichiometry of one H+ I e was measured. The H+ translocation could no 
longer be measured when the uncoupler FCCP or valinomycin plus nigeri-
cin were present. The electrogenic potassium ion uptake could also be 
measured. Its stoichiometry was one K+ le, as expected. Discussing the 
mechanism of the transfer reactions, the H+ transfer was attributed to a 
hypothetical component Z (139), which in our opinion may be ubiquinone, 
or the cytochrome b dimer. 
The rate of electron flow from duroquinol to cytochrome c appears to 
be controlled by the membrane potential ~t/J (140). This was concluded 
from experiments with a complex III reinserted into phospholipid vesicles, 
where a membrane potential was created by means of a valinomycin-
induced potassium effiux (141). The membrane potential was estimated 
from the inside: outside distribution of safranine. The effect of a pH gra-
dient ~pH can not yet be determined due to the lack of a reliable indicator 
for the pH inside the vesicles, and due to the strong pH-dependence of the 
duroquinol : cytochrome c reductase itself. 
CYTOCHOME b IN SITU The literature on cytochrome b in situ is 
abundant and highly controversial. For detailed information the reader is 
referred to recent reviews (7, 71, 77, 90, 118, 126, 142). In the following only 
some classical experiments indicating the existence of two cytochromes b 
in complex Ill, and the two main proposed mechanisms of electrogenic 
proton transport governing at this region of the electron transfer chain are 
discussed. A mobile carrier-mediated hydrogen ion transport (121) is 
compared with a fixed protein-mediated mechanism (118), i.e. the proton-
motive ubiquinone cycle is opposed to a protein-linked proton pump. 
In the early fifties two types of cytochrome b were distinguished by 
spectrophotometry (143). In mitochondria and submitochondrial particles 
about one half of cytochrome b was reducible by succinate. This part 
showed an absorbance maximum at 562 nm, and was named cytochrome 
bK in honor of D. Keilin (144). The second half of cytochrome b could be 
reduced by succinate in the presence of antimycin, or by dithionite. Its 
absorbance maximum occurs at 566 nm. It was called cytochrome bT • It 
was supposed to be a high energy intermediate (74, 145). The simplest 
explanation for the antimycin-dependent reduction of cytochrome b-566, 
which was found in redox titrations with substrate couples (136, 146), is an 
increase of its half-reduction potential. In contrast to these studies, in 
potentiometric redox titrations an increase of the half-reduction potentials 
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of cytochromes b imposed by antimycin could not be detected (147). This 
disagreement could be due to reaction of the artificial redox mediators at 
different points from that of the physiological electron donors (148). 
It is now generally accepted that the mitochondrial electron transfer 
complexes convert the free energy of oxidation into an electrochemica1 
proton gradient aJlH+, which can be used for the synthesis of ATP and 
other energy-requiring reactions (8). In principle, a proton gradient is neces-
sarily produced if, in the first place, the substrate is oxidized at one side and 
the product is reduced at the other side of the membrane; and if, second, 
the oxidation of the substrate involves the production of protons, and the 
reduction of the product involves the consumption of protons. Different or 
additional mechanisms for the formation of aJlH+ have to be postulated, 
however, if 1. the chemical redox reactions are not associated with the 
binding or dissociation of protons; 2. the redox reactions and/or the move-
ment of protons occur at the same side of the membrane, or 3. too few 
protons are produced or consumed to account for the energy required for 
A TP synthesis. 
The protonmotive ubiquinone cycle has been formulated to establish a 
2H+ / e stoichiometry at site 11 (121), obtained when ubiquinone is arranged 
at two different positions in the electron transfer chain (121, 149). It was 
placed between cytochrome band Cb according to the hypothetical scheme 
shown in Figure 6, which represents a slight modification of the original 
one. The proposed mechanism will be explained going through one turn of 
the cycle. To start the cycle, it is proposed that the NADH-dehydrogenase 
transfers one electron on Qin. This reaction involves the uptake of one proton 
from matrix side. The formed QHi~ radical binds to cytochrome bin, which 
may be identical with cytochrome b-566. Subsequently, this cytochrome 
accepts an e from bout (maybe identical with cytochrome b-562), and re-
deh. in : (e-
+ H. In 
cyt.b t + QH· ~ _ out 
e 
'" 
QH· in + cyt.b in 
cytosolic side 
r -
1
20
"' 
matrix side 
Figure 6 Hypothetical scheme of a protonmotive Ubiquinone cycle. 
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duces therewith QHi~ radical to QH2ill' This reaction involves a second 
H+ uptake from matrix side. QH2in is then released from the reaction center 
of bin and transverses the lipid bilayer ofthe mitochondrial inner membrane 
by an unknown mechanism. It is there bound to the reaction center of the 
iron-sulfur protein, which accepts one e from QH2out. This reaction involves 
a proton release to cytosolic side. QH"out radical is released from the iron-
sulfur center arid transferred to bout. The heme center of bout accepts an e 
that is fed subsequently into the heme center of bin. The reaction leading 
to the formation of Qout involves a second H+ release to the cytosolic side. 
Retransfer of Qout back across the membrane to the inner side completes 
the cycle. In contrast to (150), the half-life time of the QH" radical seems 
not to be the most critical part of the proposed mechanism, since it can be 
visualized as a QH" radical species bound to the respective reaction centers. 
The ubiquinone cycle represents for the most part "paper chemistry." 
Essential aspects, such as the existence of QH" radical, the occurrence of 
ubiquinone as reductant and oxidant of b cytochromes, and the sidedness 
of the redox centers, are at present not supported by experimental evidence. 
As an alternative mechanism to the double-arrangement of ubiquinone, a 
proton transport by a protein-linked pump mechanism has been visualized. 
Such a mechanism has been detected for bacteriorhodopsin (151, 152), and 
is under discussion for complex IV (153, 154). The following description is 
an extension of a published minimum model (94). It postulates that cyto-
chrome b is a primary energy transformer at site 11, i.e. that cytochrome 
b constitutes a proton pump, or is at least an essential part of it. 
The proposed transfer mechanism consists of a sequence of six reactions 
(Figure 7). The model is based on the phenomenon that a redox change of 
the heme center of cytochrome b is linked with a pK change of an amino 
acid residue R of the protein moiety. The pK of R changes from a lower 
to a higher value when ferricytochrome b is converted to ferrocytochrome 
b (135, 155). The protonation reaction precedes the reduction reaction. In 
reaction 1 group R accepts a proton from the matrix face according to its 
pK value of 7 and the prevailing pH in the matrix space. In reaction 2 an 
e is accepted from the presumptive donor ubiquinol. The pK of R shifts 
from 7.0 to a value higher than 8.5 in the reduced state. As a consequence 
of the electron reception a conformational change of the molecule is induced 
involving a movement of RH from matrix to cytosolic position (reaction 
3). The migration of group R may occur over only a short distance of some 
angstroms as has been discussed in models for a conformational coupling 
of ~ILH+ to ATP synthesis (156), and of ~E to creation of a membrane 
potential (157). In each final position group R may be linked to distinct 
proton channels as has been proposed for bacteriorhodopsin (151, 152). 
Group R can be considered as the gate of the proton pump. 
b-TYPE CYTOCHROMES 307 
R~X -fO;:\, R 
C 6 \..V 
H;ut 5 ~Hin 
RH~x ox RH 
C m 
e- 4 (£e--QH2 
RHlf] RH red ~3_ red 
C m 
Figure 7 Hypothetical model of the reactions of an electron- and proton-transferring cyto-
chrome b. 
Reactions 4,5 and 6 are the symmetric back reactions of 1, 2 and 3. The 
restriction of the cycle is no migration of group R in deprotonated state 
from m to c position, and vice versa (no migration of R in protonated state 
from c to m position). This constraint has to be introduced to exclude the 
possibility of a futile cycle. The pump yields an electrogenic proton translo-
cation with a fixed IH+ le stoichiometry in contrast to a described variable 
stoichiometry (140). The equilibria of the protonation : deprotonation reac-
tions 1 and 5 are influenced by the ilJ1H+' A high phosphorylation potential 
increases the proton gradient ilH+ with an increase of the H+ concentration 
at the inner face of the mitochondrial membrane. Thus the equilibria of 
reactions 5 and 1 are shifted in reverse direction. Electrons will be driven 
in reverse direction and transferred onto Ubiquinone and various redox 
centers of complex I. Eventually an accumulation of bH will occur, known 
as the energy-linked reduction of cytochrome b. 
So far it can only be speculated whether both monomers of the cyto-
chrome b dimer, or only cytochrome b-566 are involved in proton translo-
cation. But, independent of this, and of whether the b cytochromes are 
arranged in series or in parallel in the electron transfer chain, the model 
furnishes the principal mechanism of an electrogenic proton translocation 
brought about by a polypeptide carrying a redox center. 
BIOGENESIS AND GENETICS OF CYTOCHROME b As a result of stud-
ies on the genetics and biogenesis of the mitochondria in eukaryotic mi-
croorganisms (for review see 158-163) it has been possible to establish that 
both the structural gene and the site of translation of apocytochrome bare 
located inside the organelle. 
As shown first with Neurospora crassa, the highly purified cytochrome 
b of complex III is found to be labelled after incorporation of radioactive 
leucine in the presence of cycloheximide, a specific inhibitor of cytosolic 
ribosomes (80, 90). On the other hand, chloramphenicol, which inhibits 
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selectively the mitochondrial ribosomes, prevents the synthesis and labeling 
of the protein. This shows convincingly that cytochrome b of molecular 
weight 30,000 is translated inside the mitochondria. Analysis of complex III 
established that, apart from the 30,000 dalton cytochrome b, all other 
polypeptides, including cytochrome c 1> are provided by the cytoplasmic 
protein synthesis (164). Corresponding experiments with yeast Sac-
charomyces cerevisiae (165) showed that in complex III only a 32,000-
dalton subunit is synthesized inside the mitochondria, whereas the other 
polypeptides are extramitochondrial translation products. Accordingly, the 
heme b-carrying protein belongs, together with three subunits of cyto-
chrome oxidase and two to three subunits of ATPase complex, to the small 
number of hydrophobic proteins synthesized by the intramitochondrial 
protein-synthesizing system. 
The isolation and genetic analysis of different types of yeast mutants (166) 
that had an altered function, or properties, of complex III allowed the 
identification of the structural gene of apocytochrome b on mitochondrial 
DNA (167, 168-171). Fine-structure analysis provided evidence for the 
existence of a single structural gene for apocytochrome b which is mosaic, 
i.e. the coding regions (exons) of the gene are interrupted by noncoding 
regions (introns) (Figure 8) (167, 170, 171). 
The structural gene containing about 900 base pairs is organized in three 
coding regions which are interrupted by two non-coding regions that are 
estimated to contain 2000-4000 base pairs. The coding regions are identified 
by three clusters of drug-resistant mutations that confer increased resis-
tance in vivo and in vitro to inhibitors of electron transport from the b-type 
ANAl ANA 2 MUC 2 
DIU 2 DIU I 
MUCI FUN I 
~ ~ ~ 
~I I~ 
Base pairs 400-500 1800-3000 100-400 3200-4500 100-300 
BOX loci [JliI m CD m [[] 
COB loci A I I B I I ~ 0 I I e 
Figure 8 The spliced structural gene of apocytochrome b (of complex Ill) located on 
mitochondrial DNA. ANA, DIU, MUC, FUN, OLI designate genetic loci which confer 
resistance to inhibitors of complex III and ATPase complex. BOX (COB) designates clusters 
of mutations leading to a nonfunctional complex Ill. The dotted clusters indicate the presumed 
coding regions. Further details are described in the text. 
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cytochromes to cytochrome Cl> as antimycin (172, 173), diuron (174), 
mucidin (175), and funiculosin (176). Remarkably, resistance to each anti-
mycin, mucidin, and diuron is produced by mutations localized in two 
different clusters (177,178). Additionally, so-called mit- mutants (179,180) 
with lesions in the ubiquinone: cytochrome C reductase have been isolated. 
These mutations are all localized in the segment of mitochondrial DNA 
between loci OLll and OLl2 where the drug-resistant mutations are also 
found (see Figure 8). Initially two (181), and later five (167, 171) clusters 
of such mutations (COB or BOX according to different laboratories) were 
identified. Mutations in clusters BOX 4/5 (COB A), BOX 1 (COB C), and 
BOX 6 (COB E) affect, specifically, complex III and they are closely linked 
to the drug-resistance loci (177). The mutations in clusters BOX 3 (COB 
B) and BOX 2 (COB D) cause pleiotropic defects in both complex III and 
the cytochrome oxidase. They appear to be localized in the noncoding 
regions, which exhibit a still unknown and possibly regulatory function 
(167, 169, 182). 
Cytochrome b of the Resolved Succinate: 
Ubiquinone Reductase 
Complex 11 is the multi protein complex of the respiratory chain that trans-
fers electrons from succinate to the mitochondrial ubiquinone-lO pool. It 
consists of four polypeptides of which at least three contain redox centers. 
Their molecular weights are about 70,000, 27,000, 15,000, and 13,000 (183). 
The two largest polypeptides constitute the so-called succinate dehydroge-
nase, which can be cleaved off from the two smaller polypeptides by per-
chlorate. The 70,000-dalton polypeptide has covalently linked one mole of 
FAD (184). It contains additionally two iron-sulfur centers of the Fe2S2 
type, named center S-1 and S-2 according to EPRstudies (185). The 27,000-
dalton polypeptide contains the nonheme iron center S-3 which is an Fe4 
S4 centre (186). After perchlorate cleavage, the two small polypeptides of 
complex 11 become insoluble, and form a precipitate. The cytochrome b is 
present exclusively in the precipitate. Therefore it has to be attributed to 
one or both of these polypeptide subunits. 
Cytochrome b is present in the complex with a concentration equimolar 
to FAD. Its a-absorbance maximum lies at 560 nm in the dithionite-
reduced state. It cannot be distinguished from the cytochrome b dimer of 
complex III by such a spectrum. But fourth derivative spectral studies 
performed earlier had already detected this entity (75). It differs from the 
resolved cytochrome b of complex III in that it does not react with CO. 
It has an unusual negative reduction potential of -200 m V when it is titrated 
potentiometrically in the resolved complex 11 (187). It is hardly reduced by 
succinate, as mentioned above, but it can be oxidized by fumarate or ubiqui-
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none after a prereduction by dithionite. As described above, its functional 
characterization is still outstanding. Probably this cytochrome had already 
been isolated in 1977, but at that time it was not identified as cytochrome 
b of complex 11 (83). In these studies starting from a succinate: cytochrome 
c reductase preparation, a 17,OOO-dalton cytochrome b was obtained with 
a defective heme b content of only 10 /Lmol per gram of protein. The 
absorbance spectrum was altered, probably due to application of dodecyl-
sulfate, but typical pyridine hemochromogen spectra were found. 
The existence of a b-type cytochrome different to those of complex III 
was queried for a long time, especially because complex 11 isolated by 
ammonium sulfate fractionation is usually contaminated by 10-20% of 
complex Ill. Recent studies performed with Neurospora crassa have now 
definitely furnished evidence for the existence of a constituent b-type cyto-
chrome in complex 11 (103). The fungus was grown in the presence of high 
concentrations of chloramphenicol. These are conditions under which the 
mitochondrial protein synthesis is largely inhibited. As expected, the cyto-
chrome b of complex III was no longer synthesized. From these mito-
chondria the succinate: Ubiquinone reductase was isolated by means of an 
affinity chromatography with immobilized cytochrome c. It was eluted 
from the column in the first fractions, whereas the incomplete complex Ill, 
devoid of the cytochrome b dimer, remained bound to the column material. 
Complex 11 had a cytochrome b content like that of beef heart, showing 
the same absorbance spectrum. The authors are yet uncertain whether to 
ascribe the heme center to the isolated 28,000-dalton or the 14,OOO-dalton 
polypeptide. When beef heart complex III is isolated by hydroxyapatite 
chromatography, complex 11 comes from the column in a similar way in 
the first fractions (187). 
Literature Cited 
I. Lemberg, R., Barrett, J. 1973. Cyto-
chromes. pp. 58-121. New York: Aca-
demic. 580 pp. 
2. Hagihara, B., Sato, N., Yamanaka, T. 
1975. The Enzymes. 11:549-93 
3. Haddock, B. A., lones, C. W. 1977. 
Bacteriol Rev. 41:47-99 
4. Thauer, R. K., Jungermann, K., 
Decker, K. 1977. Bacteriol Rev. 41: 
100-80 
5. Cramer, W. A., Whitmarsh, J. 1977. 
Ann. Rev. Plant Physiol. 28:133-72 
6. DePierre, J. W., Ernster, L. 1977. Ann. 
Rev. Biochem. 46:201-62 
7. Crane, F. L. 1977. Ann. Rev. Biochem. 
46:439--69 
8. Boyer, P. D., Chance, B., Ernster, L., 
Mitchell, P., Racker, E., Slater, E. C. 
1977. Ann. Rev. Biochem. 46:955-1026 
9. Oshino, N., Imai, Y., Sato, J. 1971. J. 
Biochem. Tokyo. 69:155-67 
10. Strittmatter, P., Spatz, L., Corcoran, 
D., Rogers, M. J., Setlow, B., Redline, 
R. 1974. Proc. Natl. Acad. Sci. USA 
71:4565-69 
11. Hildebrandt, A., Estabrook, R. W. 
1971. Arch. Biochem. Biophys. 143: 
66-79 
12. Imai, Y., Sato, R. 1977. Biochem. Bio-
phys. Res. Commun. 75:420-26 
13. Hultquist, D. E., Passon, P. G. 1971. 
Nature New Bioi. 229:252-54 
14. Hultquist, D. E. 1978. Methods En-
zymol. 52:463-73 
15. Spatz, L., Strittmatter, P. 1971. Proc. 
Natl. Acad. Sci. USA 68:1042-46 
16. Strittmatter, P., Rogers, M. J., Spatz, L. 
1972. J. Bioi. Chem. 247:7188-94 
17. Ozols, J. 1974. Biochemistry 13:426-34 
18. Tsugita, A., Kobayashi, M., Tani, S., 
Kyo, S., Rashid, M. A., Yoshida, Y., 
Kajihara, T., Hagihara, B. 1970. Proc. 
Natl. Acad. Sci. USA 67:442-47 
19. Mathews, F. S., Levine, M., Argos, P. 
1972. J. Mol BioI. 64:449-M 
20. Ito, A., Sato, R. 1968. J. Biol Chem. 
243:4922-30 
21. Strittmatter, P., Fleming, P., Connors, 
M., Corcoran, D. 1978. Methods En-
zymol 52:97-101 
22. Ozols, J., Gerard, C. 1977. Proc. Natl 
Acad. Sci. USA 74:3725-29 
23. Ozols, J., Gerard, C. 1977. J. BioI. 
Chem. 252:8549-53 
24. Fleming, P. J., Dailey, H. A., Corcoran, 
D., Strittmatter, P. 1978. J. BioI. Chem. 
253:5369-72 
25. Takagaki, Y., Gupta, C. M., Nihei, K., 
Gerver, G. E., Khorana, H. G. 1979. 
Int. Congr. of Biochem., 11th, Toronto. 
05-4-R55 (Abstr.) 
26. Chou, P. Y., Fasman, G. D. 1977. J. 
Mol Biol 115:135-75 
27. Chou, P. Y., Fasman, G. D. 1977. 
Trends Biochem. Sci. 2:128-31 
28. Ozols, J., Strittmatter, P. 1969. J. BioI. 
Chem. 244:6617-18 
29. Enoch, H. G., Catala, A., Strittmatter, 
P. 1976. J. BioI. Chem. 251:5095-5103 
30. Mihara, K., Sato, R. 1978. Methods En-
zymol 52:102-8 
31. Mihara, K., Sato, R. 1975. J. Biochem. 
Tokyo 78:1057-73 
32. Spatz, L., Strittmatter, P. 1973. J. BioI. 
Chem. 248:793-99 
33. Takesue, S., Omura, T. 1970. J. Bio-
chem. Tokyo 67:267-76 
34. Strittmatter, P., Enoch, H. G. 1978. 
Methods Enzymol 52:188-93 
35. Rogers, M. J., Strittmatter, P. 1975. J. 
BioI Chem. 250:5713-18 
36. Strittmatter, P., Rogers, M. J. 1975. 
Proc. Natl. Acad. Sci. USA 72:2658-61 
37. Strittmatter, P., Enoch, H. G., Fleming, 
P. 1978. Methods. Enzymol. 52:206-11 
38. Douglas, R. H., Hultquist, D. E. 1978. 
Proc. Natl Acad. Sci. USA 75:3118-22 
39. Passon, P. G., Huitquist, D. E. 1972. 
Biochim. Biophys. Acta 275:62-73 
40. Hultquist, D. E., Dean, R. T., Douglas, 
R. H. 1974. Biochem. Biophys. Res. 
Commun. 60:28-34 
41. Shipp, W. S. 1972. Arch. Biochem. Bio-
phys. 150:459-72 
42. Haddock, B. A., Schairer, H. U. 1973. 
Eur. J. Biochem. 35:34-45 
43. Itagaki, E., Hager, L. P. 1966. J. Biol 
Chem. 241:3687-95 
44. Itagaki, E., Hager, L. P. 1968. Biochem. 
Biophys. Res. Commun. 32:1013-19 
b-TYPE CYTOCHROMES 311 
45. Ashcroft, J. R., Haddock, B. A. 1975. 
Biochem. J. 148:349-52 
46. Mathews, F. S., Bethge, P. H., Czerwin-
ski, E. W. 1979. J. Biol Chem. 254: 
1699-1706 
47. Enoch, H. G., Lester, R. L. 1974. Bio-
chem. Biophys. Res. Commun. 61: 
1234-41 
48. Enoch, H. G., Lester, R. L. 1975. J. 
Biol Chem. 250:6693-705 
49. MacGregor, C. H. 1975. J. Bacteriol 
121:1102-10 
50. C1egg, R. A. 1976. Biochem. J. 153: 
533-41 
51. MacGregor, C. H. 1978. Methods. En-
zymol. 53:347-55 
52. MacGregor, C. H., Schnaitman, C. A., 
Normansell, D. E., Hodgins, M. G. 
1974. J. Biol Chem. 249:5321-27 
53. Taniguchi, S., Itagaki, E. 1960. Bio-
chim. Biophys. Acta 44:263-79 
54. Forget, P. 1974. Eur. J. Biochem. 
42:325-32 
55. Bray, R. C., Vincent, S. P., Lowe, D. J., 
Clegg, R. A., Garland, P. 1976. Bio-
chem. J. 155:201-3 
56. Lund, K., DeMoss, J. A. 1976. J. Bioi. 
Chem. 251:2207-16 
57. MacGregor, C. H. 1975. J. Bacteriol 
121:1111-16 
58. Showe, M. K., DeMoss, J. A. 1968. J. 
Bacteriol. 95:1305-13 
59. Ruiz-Herrera, J., DeMoss, J. A. 1969. 
J. Bacteriol. 99:720--29 
60. MacGregor, C. H. 1976. J. Bacteriol 
126: 122-31 
61. Boxer, D. H., Clegg, R. A. 1975. FEBS 
Lett. 60:54-57 
62. MacGregor, C. H., Christopher, A. R. 
1978. Arch. Biochem. Biophys. 185: 
204--13 
63. Jones, R. W., Garland, P. B. 1977. Bio-
chem. J. 164:199-211 
64. Garland, P. B., Jones, R. W. 1977. In 
Structure and Function of Energy-
Transducing Membranes, ed. K. van 
Dam, F. B. van Gelder, pp. 117-26. 
Amsterdam:Elsevier 
65. Unden, G., Hackenberg, H., Kroger, A. 
1980. Biochim. Biophys. Acta. In press 
66. Kroger, A., Winkler, E., Innerhofer, 
A., Hackenberg, H., Schiigger, H. 1979. 
Eur. J. Biochem. 94:465-75 
67. Kroger, A., Innerhofer, A. 1976. Eur. J. 
Biochem. 69:497-506 
68. Kroger, A. 1978. See Ref. 71, pp. 96-
105 
69. Kroger, A. 1978. Biochim. Biophys. 
Acta 505:129-45 
70. Hatefi, Y., Stiggal, D. L. 1976. The En-
zymes 13:175-297 
312 VON JAGOW & SEBALD 
71. Hatefi, Y., Galante, Y. M. 1978. In En-
ergy Conservation in Biological Mem-
branes, ed. G. Schafer, M. Klingenberg, 
pp. 19-30. Berlin: Springer 
72. Nelson, B. D., Gellerfors, P. 1978. 
Methods Enzymol. 53:80-91 
73. Hatefi, Y. 1980. In press 
74. Chance, B., Wilson, D. F., Dutton, P. 
L., Erecinska, M. 1970. Proc. Natl. 
Acad. Sci. USA .66:1175-82 
75. Davis, K. A., Hatefi, Y., Poff, K. L., 
Butler, W. L. 1973. Biochim. Biophys. 
Acta 325:341-56 
76. Rieske, J. S., Baum, H., Stoner, C. D., 
Lipton, S. H. 1967. J. BioI. Chem. 
242:4854--66 
77. Rieske, J. S. 1976. Biochim. Biophys. 
Acta 456:195-246 
78. Goldberger, R., Smith, A. L., Tisdale, 
H., Bomstein, R. 1961. J. BioI. Chem. 
236:2788-93 
79. von Jagow, G., Schagger, H., Engel, W. 
D., Machleidt, W., Machleidt, I. 1978. 
FEBS Lett. 91:121-25 
80. Weiss, H., Ziganke, B. 1974. Eur. J. 
Biochem. 41 :63-71 
81. Weiss, H., Ziganke, B. 1978. Methods 
Enzymol. 53:212-21 
82. Ohnishi, K. 1966. J. Biochem. 59:1-8 
83. Yu, C., Yu, L., King, T. E. 1975. Bio-
chem. Biophys. Res. Commun. 66: 
1194--1200 
84. Lin, L. F. H., Beattie, D. S. 1978. J. 
BioI. Chem. 253:2412-18 
85. Goldberger, R., Pumphrey, A., Smith, 
A. 1962. Biochim. Biophys. Acta 58: 
307-13 
86. Ohnishi, K. 1966. J. Biochem. 59:17-23 
87. Deleted in press 
88. Capaldi, R., Vanderkooj, G. 1972. Proc. 
Natl. Acad. Sci. USA 69:930-32 
89. Weiss, H., Ziganke, B. 1975. in Elec-
tron Transfer Chains and Oxidative 
Phosphorylation, ed. E. Quagliariello, S. 
Papa, F. Palmieri, E. C. Slater, N. Sili-
prandi, pp. 15-22. Amsterdam: North-
Holland 
90. Weiss, H. 1976. Biochim. Biophys. Acta 
456:291-313 
91. Tanford, C., Nozaki, Y., Reynolds, J. 
A., Makino, S. 1974. Biochemistry 
13:2369-76 
92. Wikstrom, M. K. F. 1973. Biochim. 
Biophys. Acta 301:155-93 
93. Weiss, H., Ziganke, B. 1976. See Ref. 
160, pp. 259-67 
94. von Jagow, G. 1978. See Ref. 71 pp. 
43-52 
95. Dutton, P. L., Wilson, D. F., Lee, C. P. 
1971. Biochemistry 9:5077-82 
96. Dutton, P. L., Wilson, D. F. 1974. Bio-
chim. Biophys. Acta 346:165-212 
97. Hatefi, Y. 1978. Methods Enzymol. 53: 
35-40 
98. Yu, C. A., Yu, L., King, T. E. 1974. J. 
BioI. Chem. 249:4905-10 
99. Marres, C. A. M., Slater, E. C. 1977. 
Biochim. Biophys. Acta 462:531-48 
100. Siedow, J. N., Power, S., De La Rosa, 
F. F., Palmer, J. 1978. J. BioI. Chem. 
253:2392-99 
101. von Jagow, G., Schagger, H., Enge!, W. 
D., Riccio, P., Kolb, H. J., Klingenberg, 
M. 1978. Methods Enzymol. 53:92-98 
102. Weiss, H., Juchs, B., Ziganke, B. 1978. 
Methods Enzymol. 53:99-112 
103. Weiss, H., Kolb, H. J. 1979. Eur. J. 
Biochem. 99: 139-49 
104. von Jagow, G., Schagger, H., Riccio, P., 
Klingenberg, M., Kolb, H. J. 1977. Bio-
chem. Biophys. Acta 462:549-58 
105. Wingfie!d, P., Arad, T., Leonard, K., 
Weiss, H. 1979. Nature 280:696-97 
106. Bell, R. L., Sweetland, J., Ludwig, B., 
Capaldi, R. A. 1979. Proc. Natl. Acad. 
Sci. USA 76:741-45 
107. von Jagow, G., Engel, W. D., Riccio, P., 
Schagger, H. 1976. See Ref. 160 
pp. 267-72 
108. Bell, R. L., Capaldi, R. A. 1976. Bio-
chemistry. 15:996-1001 
109. Gellerfors, P., Lunden, M., Nelson, B. 
D. 1976. Eur. J. Biochem. 67:463-68 
110. Riccio, P., Schagger, H., Enge!, W. D., 
von Jagow, G. 1977. Biochim. Biophys. 
Acta 459:250-62 
111. Rieske, J. S., MacLennan, D. H., Cole-
man, R. 1964. Biochem. Biophys. Res. 
Commun. 15:338-44 
112. Das Gupta, U., Rieske, J. S. 1973. Bio-
chem. Biophys. Res. Commun. 54: 
1247-53 
113. Weiss, H. 1978. See Ref. 71, pp. 31-42 
114. Gellerfors, P., Nelson, B. D. 1977. Eur. 
J. Biochem. 80:275-82 
115. Smith, R. J., Capaldi, R. A. 1977. Bio-
chemistry 16:2629-33 
116. Erecinska, M., Wilson, D. F. 1979. 
Arch. Biochem. Biophys. 192:80-85 
117. Nelson, B. D., Gellerfors, P. 1974. Bio-
chim. Biophys. Acta 357:358-64 
118. Papa, S. 1976. Biochim. Biophys. Acta 
456:39-84 
119. Klingenberg, M. 1968. In Biological 
Oxidations, ed. T. P. Singer, pp. 3-54. 
New York: Interscience 
120. Kroger, A., Klingenberg, M. 1970. 
Vitam. Horm. NY. 28:533-74 
121. Mitchell, P. 1975. FEBS Lett. 56:1-6 
122. Trumpower, B. L., Edwards, C. A. 
1979. FEBS Lett. 100:13-6 
123. Trumpower, B. L., Edwards, C. A. 
1979. J. BioI. Chem. 254:8697-8706 
124. Bosshard, H. R., Zurrer, M., Schiigger, 
H., von Jagow, G. 1979. Biochem. Bio-
phys. Res. Commun. 89:250-57 
125. Wan, Y. P., Williams, R. H., Folkers, 
K., Leung, K. H., Racker, E. 1975. 
Biochem. Biophys. Res. Commun. 63: 
11-15 
126. Trumpower, B. L., Katki, A. 1979. In 
Membrane Proteins in Energy Trans-
duction, ed. R. A. Capa1di, pp. 89-206. 
New York: Dekker 
127. Slater, E. C. 1973. Biochim. Biophys. 
Acta 301:129-54 
128. Rieske, J. S., Baum, H., Stoner, C. D., 
Lipton, S. H. 1967. J. Bioi. Chem. 
242:4854-66 
129. Rieske, J. S., Das Gupta, U. 1972. 
FEBS Lett. 20:316-20 
130. Berden, J. A., Slater, E. C. 1970. Bio-
chim. Biophys. Acta 216:237-49 
131. Berden, J. A., Slater, E. C. 1972. Bio-
chim. Biophys. Acta 256:199-215 
132. Schiigger, H. 1979. Isolation des Cytoch-
rom b von Komplex III aus Rinderherz-
mitochondrien. PhD thesis. Universitiit 
Munchen, Munchen, FRG. 
133. Rieske, J. S. 1971. Arch. Biochem. 
145:179-93 
134. Wilson, D. F., Koppelman, M., Erecin-
ska, M., Dutton, P. L. 1971. Biochem. 
Biophys. Res. Commun. 44:759-66 
135. Wilson, D. F., Erecinska, M., Leigh, J. 
S. 1972. Arch. Biochem. Biophys. 
151:112-21 
136. Wikstrom, M. K. F., Berden, J. A. 
1972. Biochim. Biophys. Acta 283: 
403-20 
137. Reed, J., Reed, T. A., Hess, B. 1978. 
Eur. J. Biochem. 91:255-61 
138. Reed, J., Reed, T. A., Hess, B. 1979. 
Proc. Natl. Acad. Sci. USA 76: 1045-48 
139. Leung, K. H., Hinkle, P. C. 1975. J. 
Bioi. Chem. 250:8467-71 
140. Guerrieri, F., Nelson, B. D. 1975. FEBS 
Lett. 54:339-42 
141. Wielburski, A., Nelson, B. D. 1978. 
FEBS Lett. 93:69-72 
142. Wainio, W. W. 1977. J. Bioenerg. 
Biomembr. 9:321-35 
143. Chance, B. 1958. J. Bioi. Chem. 233: 
1223-29 
144. Keilin, D. 1925. Proc. R. Soc. London 
Ser. B 98:312 
145. Wilson, D. F., Dutton, P. L. 1970. Bio-
chem. Biophys. Res. Commun. 39: 
59-64 
146. von Jagow, G. 1975. See Ref. 89, pp. 
23-30 
147. Dutton, P. L., Erecinska, M., Sato, N., 
Mukai, Y., Pring, M., Wilson, D. F. 
1972. Biochim. Biophys. Acta 267:15-24 
b-TYPE CYTOCHROMES 313 
148. Walz, D. 1979. Biochim. Biophys. Acta 
505:279-353 
149. Mitchell, P. 1975. FEBS Lett. 59: 
137-39 
150. Kroger, A. 1976. FEBS Lett. 65:278-80 
151. Oesterhelt, D. 1976. Angew. Chem. 
88:16-24 
152. Stoeckenius, W., Lozier, R. H., Bogo-
molni, R. A. 1979. Biochim. Biophys. 
Acta 505:215-78 
153. Wikstrom, M. K. F. 1977. Nature. 
266:271-73 
154. Wikstrom, M., Krab, K. 1979. Biochim. 
Biophys. Acta 549: 177-222 
155. Urban, P. F., Klingenberg, M. 1969. 
Eur. J. Biochem. 9:519-25 
156. Boyer, P. D. 1975. FEBS Lett. 58:1-6 
157. Klingenberg, M. 1975. In Energy 
Transformation in Biological Systems 
CCIBA Found. Symp. 31), Amsterdam: 
EIsevier, pp. 23-40 
158. Schatz, G., Mason, T. L. 1974. Ann. 
Rev. Biochem. 43:51-87 
159. Saccone, c., Kroon, A. M. 1976. The 
Genetic Function of Mitochondrial 
DNA. Amsterdam: EIsevier. 854 pp. 
160. Bucher, Th., Neupert, W., Sebald, W., 
Werner, S. 1976. Genetics and Biogene-
sis of Chloroplasts and Mitochondria. 
Amsterdam: EIsevier. 895 pp. 
161. Bandlow, W., Schweyen, R. J., Wolf, 
K., Kaudewitz, F. 1977. Mitochondria 
1977. Berlin: Waiter de Gruyter: 
669 pp. 
162. Tzagoloff, A., Macino, G., Sebald, W. 
1979. Ann. Rev. Biochem. 48:419-41 
163. Borst, P. 1972. Ann. Rev. Biochem. 
41:333-76 
164. Weiss, H., Ziganke, B. 1977. See Ref. 
161, pp. 463-72 
165. Katan, M. B., VanHarten-Loosbrock, 
N., Groot, G. S. P. 1976. Eur. J. Bio-
chem. 70:409-17 
166. Dujon, B., Colson, A. M., Slonimski, P. 
P. 1977. See Ref. 161, pp. 579-669 
167. Slonimski, P. P., Pajot, P., Jacq, C., 
Foucher, M., Perrodin, G., Kochko, A., 
Lamouroux, A. 1978. In Biochemistry 
and Genetics of Yeast-Pure and Ap-
plied Aspects, ed. M. Bacila, B. L. Ho-
recker, A. O. M. Stoppani, pp. 339-68. 
New York: Academic 
168. Claisse, M. L., Spyridakis, A., Wambi-
er-Kluppel, M. L., Pajot, P., Slonimski, 
P. P. See Ref. 167, pp. 369-90 
169. Slonimski, P. P., Claisse, M. L., 
Foucher, M., Jacq, C., Kochko, A., 
Lamouroux, A., Pajot, P., Perrodin, G., 
Spyridakis, A., Wambier-Kluppel, M. 
L. 1978. See Ref. 167, pp. 391-401 
170. Alexander, N. J., Vincent, R. D., Perl-
man, P. S., Miller, D. H., Hanson, D. 
314 VON JAGOW & SEBALD 
K., Mahler, H. R. 1979. J. BioL Chem. 
254:2471-79 
171. Haid, A., Schweyen, R. 1., Bechrnann, 
H., Kaudewitz, F., Solioz, M., Schatz, 
G. 1979. Eur. J. Biochem. 94:451-64 
172. Michaelis, G. 1976. MoL Gen. Genet. 
146:133-37 
173. Burger, G., Lang, B., Bandlow, W., 
Schweyen, R. J., Backhaus, B., Kaude-
witz, F. 1976. Biochem. Biophys. Res. 
Commun. 72:1201-8 
174. Colson, A. M., The Van, L., Convent, 
B., Briquet, M., Golfeau, A. 1977. Eur. 
J. Biochem. 74:521-26 
175. Subik, J., Kovacova, V., Takacsova, G. 
1977. Eur. J. Biochem. 73:275-86 
176. Pratje, E., Michaelis, G. 1977. Mol. 
Gen. Genet. 152:167-74 
177. Colson, A. M., Slonirnski, P. P. 1979. 
Mol. Gen. Genet. 167:287-98 
178. Colson, A. M., Michaelis, G., Pratje, E., 
Slonirnski, P. P. 1979. MoL Gen. Genet. 
167:299-300 
179. Tzagololf, A., Akai, A., Needlernan, R. 
B., ZuJch, G. 1975. J. BioL Chem. 
250:8236-42 
180. Slonirnski, P. P., Tzagololf, A. 1976. 
Eur. J. Biochem. 61:27-41 
181. Tzagololf, A., Foury, F., Akai, A. 1976. 
MoL Gen. Genet. 149:33-42 
182. Hanson, D. K., Miller, D. H., Mahler, 
H. R., Alexander, NJ., Perirnan, P.S. 
1979. J. BioL Chem. 254:2480-90 
183. Hatefi, Y. 1978. Methods Enzymol. 
53:27-35 
184. Davis, K. A., Hatefi, Y. 1971. Biochem-
istry 10:2509-16 
185. Ohnishi, T., Salerno, J. c., Winter, D. 
B., Lirn, J., Yu, C. A., Yu, L., King, T. 
E. 1976. J. BioL Chem. 251:2094--2104 
186. Ohnishi, T., Lirn, J., Winter, D. B., 
King, T. E. 1976. J. Bioi. Chem. 
251:2105-9 
187. von Jagow, G., Schagger, H., Engel, D. 
1980. FEBS Left. In press 
